UPS announced its involvement and full support of distribution efforts for Pfizer-BioNTech’s COVID-19 vaccine as part of Operation Warp Speed. Pfizer’s and BioNTech’s vaccine, approved through a U.S. Food and Drug Administration emergency use authorization (EUA), is the first to be deployed in a months-long global race to develop safe vaccines to combat the spread of the COVID-19 virus. UPS will move the Pfizer-BioNTech COVID-19 vaccine to states designated by Pfizer, Inc. based on orders received by Operation Warp Speed and CDC officials.
UPS continues its involvement with COVID-19 vaccine delivery efforts through a partnership with global pharmaceutical and medical supply distributor McKesson. Through contracts with the Centers for Disease Control and Prevention and the Assistant Secretary for Preparedness and Response to support Operation Warp Speed, McKesson is the centralized distributor for non-ultra-frozen COVID-19 vaccines and ancillary supply kits. Under its agreement with McKesson, UPS will begin delivering Moderna’s COVID-19 vaccine, which received a U.S. Food and Drug Administration Emergency Use Authorization. Moderna’s COVID-19 vaccine is the second in the U.S. to be deployed in a months-long global race to develop safe treatments against the spread of the virus.